Prescription required? yes Controlled substance? no Year of FDA approval: 2015 FDA warnings This drug has boxed warnings. A boxed warning is the most serious warning from the Food and Drug Administration (FDA). It alerts doctors and patients about drug effects that may be dangerous. Risk of ...
-in dosing to assess the tolerability of cabotegravir may be used for approximately 1 month (>28 days) prior to the initiation of cabotegravir extended-release injectable suspension (Apretude) or the combined regimen of cabotegravir and rilpivirine extended-release injectable suspension (Cabenuva)...
The first dose of oral therapy should be taken 1 month (+/-7 days) after the last injection dose of CABENUVA and continued until the day injection dosing is restarted. For oral therapy with VOCABRIA and EDURANT of durations greater than 2 months, an alternative oral regimen is recommended. ...
Especially tell your healthcare provider if you take medicine that contains rilpivirine (EDURANT, COMPLERA, JULUCA, ODEFSEY, CABENUVA).What are the possible side effects of VOQUEZNA? VOQUEZNA may cause serious side effects including:A type of kidney problem (acute tubulointersti...
The human immunodeficiency virus (HIV) is a type of virus that targets the body’s immune cells. HIV infection can be divided into three phases: acute HIV infection, chronic HIV infection, and acquired immunodeficiency syndrome (AIDS). HIV-infected people are immunosuppressed and at risk of deve...